| Date | Event |
| 3-Dec-09 | MOLECULAR INSIGHT PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibi |
| 24-Nov-09 | MOLECULAR INSIGHT PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD |
| 9-Nov-09 | Molecular Insight Pharmaceuticals, Inc Earnings Call scheduled for 4:30 pm ET today |
| 9-Nov-09 | MOLECULAR INSIGHT PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Other Even |
| 9-Nov-09 | MOLECULAR INSIGHT PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report |
| 9-Nov-09 | Earnings announcement |
| 15-Oct-09 | Coverage initiated on Molecular Insight Pharma by Brean Murray |
| 4-Sep-09 | MOLECULAR INSIGHT PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Sta |
| 2-Sep-09 | MOLECULAR INSIGHT PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD |
| 11-Aug-09 | MOLECULAR INSIGHT PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers |
| 10-Aug-09 | Molecular Insight Pharmaceuticals, Inc Earnings Call scheduled for 9:00 am ET today |
| 10-Aug-09 | MOLECULAR INSIGHT PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition |
| 7-Aug-09 | MOLECULAR INSIGHT PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report |
| 5-Aug-09 | MOLECULAR INSIGHT PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers |
| 17-Jun-09 | Price hit new 52-week high ($7.90) |
| 5-Jun-09 | MOLECULAR INSIGHT PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers |
| 15-May-09 | MOLECULAR INSIGHT PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers |
| 11-May-09 | MOLECULAR INSIGHT PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition |
| 27-Mar-09 | MOLECULAR INSIGHT PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events |
| 16-Mar-09 | MOLECULAR INSIGHT PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition |
| 13-Mar-09 | MOLECULAR INSIGHT PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report |
| 9-Mar-09 | Price hit new 52-week low ($1.15) |
| 27-Feb-09 | Price hit new 52-week low ($1.58) |
| 2-Feb-09 | MOLECULAR INSIGHT PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement |
| 5-Jan-09 | MOLECULAR INSIGHT PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers |
| 23-Dec-08 | MOLECULAR INSIGHT PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events |
| 14-Nov-08 | MOLECULAR INSIGHT PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report |
| 13-Nov-08 | MOLECULAR INSIGHT PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition |